| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5951305 | Atherosclerosis | 2010 | 7 Pages |
Abstract
EMMPRIN is upregulated during the differentiation process from CD34+ progenitor cells to foam cells, whereas its ligand, CyPA, is released. The CyPA/EMMPRIN activation pathway may play a relevant role in promoting the vulnerability of atherosclerotic plaques.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Peter Seizer, Tanja Schönberger, Moritz Schött, Michael R. Lang, Harald F. Langer, Boris Bigalke, Björn F. Krämer, Oliver Borst, Karin Daub, Olaf Heidenreich, Roland Schmidt, Stephan Lindemann, Yared Herouy, Meinrad Gawaz, Andreas E. May,